Vyvanse

In shortageOrange BookUNIISPLATC N06BA

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerTakeda Pharmaceuticals America, Inc.

CountryUS (United States)

ATC codeN06BA

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 1

ndc11
5941711701
100 TABLET, CHEWABLE in 1 BOTTLE (59417-117-01)

Annotations

UNII (FDA Substance ID)

SJT761GEGS

LISDEXAMFETAMINE DIMESYLATE

RxCUI 673579

Orange Book

N208510

ABABABABABAB

DailyMed SPL labels

1 version tracked

FDA shortage

Currently in shortage

Lisdexamfetamine Dimesylate Tablet, Chewable

Raw payload (JSON)

{
  "unii": {
    "unii": "SJT761GEGS",
    "rxcui": "673579",
    "inchikey": "CETWSOHVEGTIBR-FORAGAHYSA-N",
    "display_name": "LISDEXAMFETAMINE DIMESYLATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "704e4378-ca83-445c-8b45-3cfa51c1ecad": {
      "match": "brand_token",
      "title": "VYVANSE (LISDEXAMFETAMINE DIMESYLATE) CAPSULE VYVANSE (LISDEXAMFETAMINE DIMESYLATE) TABLET, CHEWABLE [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
      "spl_version": "81",
      "published_date": "2026-05-06"
    }
  },
  "productid": "59417-117_81d087b6-4cb4-466a-9693-679edeb062e2",
  "productndc": "59417-117",
  "dosage_form": "TABLET, CHEWABLE",
  "orange_book": {
    "appl_no": "208510",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "10MG",
        "product_no": "001",
        "approval_date": "Jan 28, 2017"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "20MG",
        "product_no": "002",
        "approval_date": "Jan 28, 2017"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "30MG",
        "product_no": "003",
        "approval_date": "Jan 28, 2017"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "40MG",
        "product_no": "004",
        "approval_date": "Jan 28, 2017"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "50MG",
        "product_no": "005",
        "approval_date": "Jan 28, 2017"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AB",
        "strength": "60MG",
        "product_no": "006",
        "approval_date": "Jan 28, 2017"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": "CII",
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "LISDEXAMFETAMINE DIMESYLATE",
  "shortage_reason": "Lisdexamfetamine Dimesylate Tablet, Chewable",
  "shortage_status": "current",
  "proprietary_name": "Vyvanse",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA208510",
  "marketing_category": "NDA",
  "nonproprietary_name": "LISDEXAMFETAMINE DIMESYLATE",
  "start_marketing_date": "20170128",
  "active_numerator_strength": "30"
}

Related drugs

Other records sharing ATC code N06BA.

Access this data programmatically

Query Vyvanse and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs